LeanLife Health Inc.
LNLHF · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $2 | $2 | $2 |
| SG&A Expenses | $4 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$1 | $0 | $0 |
| Operating Expenses | $4 | $2 | $2 | $2 |
| Operating Income | -$3 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | -$0 |
| Pre-Tax Income | -$4 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$4 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS | -0.023 | -0.02 | -0.03 | -0.058 |
| % Growth | -14.9% | 33.3% | 47.8% | – |
| EPS Diluted | -0.023 | -0.02 | -0.03 | -0.058 |
| Weighted Avg Shares Out | 158 | 103 | 67 | 41 |
| Weighted Avg Shares Out Dil | 158 | 103 | 67 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$3 | -$2 |
| % Margin | – | – | – | – |